Metraipolis › archive › dc_2ea138b8070b
Impact of SARS-CoV-2 on Severe Asthma Patients Undergoing Biological Therapy: A Multicenter Study — Europe PMC PMID:41226980
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41226980
- DOI
- 10.3390/jcm14217583
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T01:38:11.882Z
- SHA-256 of the archived text
0c5c72e82a6e06e9a75154a9e231ea271396f54c3ee4d5706e6eec296adfbc36- Stable URL of this page
https://metraipolis.com/documento/dc_2ea138b8070b
How to cite
Impact of SARS-CoV-2 on Severe Asthma Patients Undergoing Biological Therapy: A Multicenter Study — Europe PMC PMID:41226980 — Europe PMC (en), https://europepmc.org/article/MED/41226980 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ea138b8070b (Metraipolis archive dc_2ea138b8070b, sha256 0c5c72e82a6e06e9a75154a9e231ea271396f54c3ee4d5706e6eec296adfbc36)
BibTeX
@misc{dc2ea138b8070b,
title = {Impact of SARS-CoV-2 on Severe Asthma Patients Undergoing Biological Therapy: A Multicenter Study — Europe PMC PMID:41226980},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41226980},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ea138b8070b; sha256 0c5c72e82a6e06e9a75154a9e231ea271396f54c3ee4d5706e6eec296adfbc36},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41226980. Agents can read the archived copy with the MCP tool read_document.